has landed a contract with GlaxoSmithKline to provide the pharmaceutical giant with microarray-based genotyping services. Other WRAL Top Stories Microarray technology enables researchers to genetic ...
To map most of the genetic variation in the human genome, scientists need to look at several hundred thousand single nucleotide polymorphisms (SNPs) per individual. Most genotyping assays employ ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
The past decade has seen accelerated discovery of the causal genes underlying Mendelian and complex diseases as well as progress toward the goal of personalized medicine. Technological achievements ...
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback